In June, GSK released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, ...
GSK (GSK) plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization, STAT’s John Wilkerson, Lizzy Lawrence, Rachel Cohrs Zhang, and Sarah ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and ...
We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization ...
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...
The dip reflects shifting expectations around US monetary policy, with investors bracing for a tighter US Federal Reserve stance in 2025 under Donald Trump’s administration. Anticipation of higher ...
Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.72B ...
Across the sector, all eyes have been on bitcoin, which has made massive gains over the past week, reaching a new all-time high of $93,500 (£73,785) on Wednesday. At the time of writing, it was ...
Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2492.50 as on 13 Nov, 2024, 03 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback